FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns

A group of independent experts wasn’t convinced by clinical trial data from company Lykos Therapeutics, which is seeking FDA approval of MDMA-assisted treatment for post-traumatic stress disorder.